Jump to content

Myocarditis

From Wikipedia
myocarditis
class of disease, signs den symptoms
Subclass ofextrinsic cardiomyopathy, myocardial disorder, pancarditis, cardiovascular system symptom, disease Edit
Health specialtycardiology Edit
ICD-9-CM429.0 Edit
NCI Thesaurus IDC34831 Edit

Myocarditis be inflammation of de cardiac muscle. Myocarditis fi progress to inflammatory cardiomyopathy wen der be associated ventricular remodeling den cardiac dysfunction secof chronic inflammation.[1][2] Symptoms fi include shortness of breath, chest pain, decreased ability to exercise, den an irregular heartbeat.[3] De duration of problems fi vary from hours to months. Complications fi include heart failure, secof dilated cardiomyopathy anaa cardiac arrest.[3]

Myocarditis most often be secof a viral infection.[3] Oda causes dey include bacterial infections, certain medications, toxins den autoimmune disorders.[3][4] A diagnosis fi be supported by an electrocardiogram (ECG), increased troponin, heart MRI, den occasionally a heart biopsy.[3][4] An ultrasound of de heart be important to rule out oda potential causes, such as heart valve problems.[4]

Treatment dey depend on both de severity den de cause.[3][4] Dem often dey use medications such as ACE inhibitors, beta blockers, den diuretics.[3][4] A period of no exercise typically be recommended during recovery.[3][4] Corticosteroids anaa intravenous immunoglobulin (IVIG) fi be useful insyd certain cases.[3][4] Insyd severe cases, an implantable cardiac defibrillator anaa heart transplant fi be recommended.[3][4]

Insyd 2013, na about 1.5 million cases of acute myocarditis occur.[5] While people of all ages be affected, de young most often be affected.[6] E be slightly more common insyd males dan females.[3] Chaw cases be mild.[4] Insyd 2015, na cardiomyopathy, wey dey include myocarditis, result insyd 354,000 deaths, up from 294,000 insyd 1990.[7][8] De initial descriptions of de condition be from de mid-1800s.[9]

References

[edit | edit source]
  1. ↑ Suresh, Abhilash; Martens, Pieter; Tang, W. H. Wilson (October 2022). "Biomarkers for Myocarditis and Inflammatory Cardiomyopathy". Current Heart Failure Reports (in English). 19 (5): 346–355. doi:10.1007/s11897-022-00569-8. ISSN 1546-9530. PMC 9340754. PMID 35913661.
  2. ↑ Tschöpe, Carsten; Ammirati, Enrico; Bozkurt, Biykem; Caforio, Alida L. P.; Cooper, Leslie T.; Felix, Stephan B.; Hare, Joshua M.; Heidecker, Bettina; Heymans, Stephane; Hübner, Norbert; Kelle, Sebastian; Klingel, Karin; Maatz, Henrike; Parwani, Abdul S.; Spillmann, Frank (March 2021). "Myocarditis and inflammatory cardiomyopathy: current evidence and future directions". Nature Reviews Cardiology (in English). 18 (3): 169–193. doi:10.1038/s41569-020-00435-x. ISSN 1759-5002. PMC 7548534. PMID 33046850.
  3. 1 2 3 4 5 6 7 8 9 10 11 Cooper LT (April 2009). "Myocarditis". The New England Journal of Medicine. 360 (15): 1526–1538. doi:10.1056/nejmra0800028. PMC 5814110. PMID 19357408.
  4. 1 2 3 4 5 6 7 8 9 Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, et al. (February 2012). "Update on myocarditis". Journal of the American College of Cardiology. 59 (9): 779–792. doi:10.1016/j.jacc.2011.09.074. PMID 22361396.
  5. ↑ Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. (Global Burden of Disease Study 2013 Collaborators) (August 2015). "Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 386 (9995): 743–800. doi:10.1016/s0140-6736(15)60692-4. PMC 4561509. PMID 26063472.
  6. ↑ Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. (Global Burden of Disease Study 2013 Collaborators) (August 2015). "Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 386 (9995): 743–800. doi:10.1016/s0140-6736(15)60692-4. PMC 4561509. PMID 26063472.
  7. ↑ Naghavi M, Wang H, Lozano R, Davis A, Liang X, Zhou M, et al. (GBD 2013 Mortality and Causes of Death Collaborators) (January 2015). "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet. 385 (9963): 117–171. doi:10.1016/S0140-6736(14)61682-2. PMC 4340604. PMID 25530442.
  8. ↑ Wang, H; Naghavi, M; Allen, C; Barber, RM; Bhutta, ZA; Carter, A (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet (London, England). 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. ISSN 1474-547X. PMC 5388903. PMID 27733281.
  9. ↑ Cunha BA (2009). Infectious Diseases in Critical Care Medicine. CRC Press. p. 263. ISBN 978-1-4200-1960-5. Archived from the original on 2017-11-05.
[edit | edit source]
Dem retrieve am from "https://gpe.wikipedia.org/w/index.php?title=Myocarditis&oldid=84166"